In this scenario, FOXG1 over-expression in brain tumors and the herein demonstrated capability of ZIKV to downregulate FOXG1 and its downstream genes suggest a mechanism for ZIKV oncolytic action. This evidence concerns the gene FOXG1 and brain neoplasm.